COMBINATIONS COMPRISING PDE 2 INHIBITORS SUCH AS 1-ARYL-4-METHYL- [1,2,4]TRIAZOLO [4,3-A]QUINOXALINE COMPOUNDS AND PDE 10 INHIBITORS FOR USE IN THE TREATMENT OF NEUROLOGICAL OR METABOLIC DISORDERS
- Application ID: EP13731752
- Status: █ EXAMINATION IN PROGRESS
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Janssen Pharmaceutica N.V. is specialized in A61. Janssen Pharmaceutica N.V. is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.